Appendix 4C - quarterly
Melbourne, Oct 11, 2019 AEST (ABN Newswire) - Bluechiip Ltd (
ASX:BCT) recorded net sales revenue of $103k and sales receipts of $441k for the quarter, attributable to the sales of chips, readers, software and services.
Net operating cash outflow for the September 2019 quarter was $1,072,183, down from $1,282,907 in June 2019 quarter (the June quarter included the receipt of R&D Tax Incentive of $187k).
During the quarter Bluechiip successfully converted a proposal to a new OEM for the development of prototype consumables incorporating Bluechiip technology, including the delivery of a developer kit. The prototype consumables will enable our partner to test the market in their application. Bluechiip has now delivered 34 developer kits with a multitude of potential OEM partners.
Bluechiip has now progressed to full-scale manufacture of its Bluechiip Hand-Held, Multi-Vial and Matchbox readers, and importantly has completed tests in compliance with European market CE mark and United States FCC requirements. These are important to enable the full commercialisation of the Company's products in these important markets.
To view the Quarterly Report, please visit:
https://abnnewswire.net/lnk/97T850BH
About Bluechiip Limited
Bluechiip Ltd (ASX:BCT) understands that every sample - stem cells, blood, eggs, sperm and other biospecimens - is critical, so our objective is to manage each one with optimal quality in the most efficient way. Bluechiip's advanced management solution is the only one that provides sample temperature with ID in cryogenic environments to. Most importantly, this delivers confidence in every sample.
Bluechiip's unique patented technology is a MEMS-based wireless tracking solution that contains no electronics. It represents a generational change from current tracking methods such as labels (hand-written and pre-printed), barcodes (linear and 2D), and Radio Frequency Identification. Bluechiip tags are either embedded or manufactured into storage products such as vials or bags. Each product can be easily identified, and critical information such as sample temperature, is detected by readers and stored in the Bluechiip software. In addition to functioning in extreme temperatures, the Bluechiip(R) Advanced Sample management solution can survive autoclaving, gamma irradiation sterilization, humidification, centrifuging, cryogenic storage and frosting.
Bluechiip's technology has applications in healthcare, including in cryogenic storage facilities (biobanks and biorepositories), pathology, clinical trials and forensics. Other key markets include cold-chain logistics/supply chain, security/defence, industrial/manufacturing and aerospace/aviation.
Bluechiip: Delivering confidence in every sample.
| ||
|
